A Case of Wong-type Dermatomyositis with Anti-transcriptional Intermediary Factor1-Gamma Autoantibody

Authors

  • Donlaporn Chuenwipasakul DIVISION OF DERMATOLOGY, DEPARTMENT OF INTERNAL MEDICINE, FACULTY OF MEDICINE, CHULALONGKORN UNIVERSITY, BANGKOK, THAILAND.
  • Jade Wititsuwannakul DIVISION OF DERMATOLOGY, DEPARTMENT OF INTERNAL MEDICINE, FACULTY OF MEDICINE, CHULALONGKORN UNIVERSITY, BANGKOK, THAILAND
  • Pawinee Rerknimitr DIVISION OF DERMATOLOGY, DEPARTMENT OF INTERNAL MEDICINE, FACULTY OF MEDICINE, CHULALONGKORN UNIVERSITY, BANGKOK, THAILAND

Keywords:

Dermatomyositis, pityriasis rubra pilaris, wong-type dermatomyositis

Abstract

Dermatomyositis (DM) belongs to the spectrum of the idiopathic inflammatory myopathies characterized by muscle weakness and skin rashes.  Wong-type dermatomyositis is one of rare variants of DM.

To the best of our knowledge, there are a few reported cases of Wong-type dermatomyositis. We herein report a case of DM presented with atypical cutaneous manifestations typified by hyperkeratotic follicular papules. Histologic features were similar to those of pityriasis rubra pilaris. Treatment with systemic prednisolone and hydroxychloroquine led to well control of cutaneous and muscle symptoms.

References

DeWane ME, Waldman R, Lu J. Dermatomyositis: Clinical features and pathogenesis. J Am Acad Dermatol 2020;82:267-81.

Lupton JR, Figueroa P, Berberian BJ, Sulica VI. An unusual presentation of dermatomyositis: the type Wong variant revisited. J Am Acad Dermatol 2000;43:908-12.

Haro R, Revelles JM, Fariña Mdel C, Martín L, Requena L. Wong's dermatomyositis: a new case and review of the literature. Int J Dermatol 2013;52:466-70.

Umanoff N, Fisher A, Carlson JA. Wong-Type Dermatomyositis Showing Porokeratosis-Like Changes (Columnar Dyskeratosis): A Case Report and Review of the Literature. Dermatopathology (Basel) 2015;2:1-8.

Caporali R, Cavagna L, Bellosta M, Bogliolo L, Montecucco C. Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of Wong's dermatomyositis. Clin Rheumatol 2004;23:63-5.

Sato S, Kuwana M. Utility of dermatomyositis-specific autoantibodies for diagnosis and clinical subsetting. Int. J. Clin. Rheumatol 2015;10:257–71.

Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 2016;280:8-23.

Tartar DM, Chung L, Fiorentino DF. Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis. Clin Dermatol 2018;36:508-24.

Fiorentino DF, Kuo K, Chung L, Zaba L, Li S, Casciola-Rosen L. Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis. J Am Acad Dermatol 2015;72:449-55.

Nakashima R. Clinical significance of myositis-specific autoantibodies. Immunol Med 2018;41:103-12.

Downloads

Published

2021-03-16

How to Cite

Chuenwipasakul, D., Wititsuwannakul, J., & Rerknimitr, P. (2021). A Case of Wong-type Dermatomyositis with Anti-transcriptional Intermediary Factor1-Gamma Autoantibody. Thai Journal of Dermatology, 37(1), 10–14. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/247875

Issue

Section

Case Report